As of 2026-10-03, the Fair Value of Ondine Biomedical Inc (OBI.L) is -14.51 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.75 GBP, the upside of Ondine Biomedical Inc is -248.84%.
With the market price of 9.75 GBP and our fair value calculation, Ondine Biomedical Inc (OBI.L) is not a good investment. Investing in OBI.L stocks now will result in a potential loss of 248.84%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -50.09 | -19.37 | -14.41 | -19.10 | -29.52 | -26.50 |
| YoY growth | -1,437.86% | 61.32% | 25.60% | -32.51% | -54.56% | -287.60% |
| Market Cap (mil) | 52.69 |
| P/E | |
| Forward P/E |
| EPS | -5.46 |
| Avg earnings growth rate | -287.60% |
| TTM earnings | -29.52 |